Product Information
DALIRESP 250 MCG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $14.9826 per EA under NDC 00310008839. Its NADAC has been published 397 times since Nov 21, 2018.
The High Outlier badge above means this manufacturer's average price in the roflumilast market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 ug/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310008839
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
ROFLUMILASTApproval Type
New Drug (NDA)
FDA Application
NDA022522On Market Since
7/1/2015
Pharmacological Classes
Price Statistics
The NADAC for DALIRESP 250 MCG TABLET has been published 397 times since Nov 21, 2018, and over the history we have for it it has risen 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.9826 per EA |
|---|---|
| All-time high | $14.9826 (Jun 24, 2026) |
| All-time low | $11.2112 (Nov 21, 2018) |
| 52-week high | $14.9826 |
| 52-week low | $14.5311 |
| Median price | $13.3520 |
| Average price | $13.2197 |
| Largest weekly change | +6.0% (Jul 15, 2020) |
| Weeks tracked | 397 |
| Tracking since | Nov 21, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DALIRESP 250 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DALIRESP 250 MCG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $14.9826 per EA (NDC 00310008839), effective Jun 24, 2026.
How has the price of DALIRESP 250 MCG TABLET changed over time?
Over the history we have for it, the NADAC for DALIRESP 250 MCG TABLET has risen 33.6%. It has been tracked across 397 weekly CMS publications since Nov 21, 2018.
What are the highest and lowest recorded NADAC prices for DALIRESP 250 MCG TABLET?
Since Nov 21, 2018, the NADAC for DALIRESP 250 MCG TABLET has ranged from a low of $11.2112 (Nov 21, 2018) to a high of $14.9826 (Jun 24, 2026), with a median of $13.3520 per EA.
Are there cheaper alternatives to DALIRESP 250 MCG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DALIRESP 250 MCG TABLET, but none are currently priced below it.
Who manufactures DALIRESP 250 MCG TABLET?
DALIRESP 250 MCG TABLET (NDC 00310008839) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.